Back to today’s briefing

Story perspectives

Oxford and Seattle Launch Groundbreaking TB Vaccine Trial

3/30/2025

39 4

Summary

Story summary

The University of Oxford and Seattle Children's Research Institute have joined forces to launch the TB045 trial, testing the promising new TB vaccine, ID93+GLA-SE, on healthy adults. This vital study, which commenced in January 2023, seeks to fill the gap left by the BCG vaccine, which fails to provide lasting protection against tuberculosis.

1 of 1

Story summary

The University of Oxford and Seattle Children's Research Institute have joined forces to launch the TB045 trial, testing the promising new TB vaccine, ID93+GLA-SE, on healthy adults. This vital study, which commenced in January 2023, seeks to fill the gap left by the BCG vaccine, which fails to provide lasting protection against tuberculosis.